Prevention of Esophageal Varices by Beta-Adrenergic Blockers

PHASE3CompletedINTERVENTIONAL

Enrollment

213

Participants

Timeline

Start Date

August 31, 1993

Primary Completion Date

September 30, 2002

Study Completion Date

September 30, 2002

Conditions

Esophageal and Gastric VaricesLiver CirrhosisPortal Hypertension

Interventions

DRUG

Timolol Maleate

DRUG

Placebo

Trial Locations (5)

Yale University Sch. of Medicine, New Haven

VA CT Healthcare System, West Haven

The Faulkner Hospital, Boston

Hospital Clinic I Provincial de Barcelona, Barcelona

Royal Free Hospital, Hampstead

All Listed Sponsors

collaborator

Yale University

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00006398 - Prevention of Esophageal Varices by Beta-Adrenergic Blockers | Biotech Hunter | Biotech Hunter